Who has invested in Shorla Pharma?

Kurma Partners, Seroba Life Sciences, Enterprise Ireland are named among the investors backing Shorla Pharma.

Shorla Pharma Funding: $35M Raised, Series B

Shorla Pharma funding overview

Shorla Pharma is based in Cambridge. Shorla Pharma has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B. Investors on record include Kurma Partners, Seroba Life Sciences, Enterprise Ireland. 3 distinct backers are named across the disclosed rounds.

Shorla Pharma at a glance

Total raised: $35M
Latest round: Series B
Headquarters: Cambridge
Notable investors: Kurma Partners, Seroba Life Sciences, Enterprise Ireland

Frequently asked about Shorla Pharma funding

How much has Shorla Pharma raised?: Shorla Pharma has raised $35M in total disclosed funding across the rounds on record.
Who has invested in Shorla Pharma?: Kurma Partners, Seroba Life Sciences, Enterprise Ireland are named among the investors backing Shorla Pharma.
What was the latest Shorla Pharma funding round?: The most recent disclosed round is a Series B.
Where is Shorla Pharma based?: Shorla Pharma is based in Cambridge.

Totals shown for Shorla Pharma aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

Shorla Pharma Funding: $35M Raised, Series B

Shorla Pharma funding overview

Shorla Pharma at a glance

Frequently asked about Shorla Pharma funding

Companies related to Shorla Pharma (36)

Browse related funding lists (6)